shortage of tirzepatide Update: On December 19th the FDA ruled the tirzepatide was resolved, however is giving a grace period for compounding pharmacies to continuing manufacturing. This grace period is 60 days. On FDA: Shortage of Weight Loss

Engineering: This "No DAC" variant features four specific amino acid substitutions (Tetrasubstitution) that protect it from DPP-IV enzymatic cleavage, extending its biological activity to 30-60 minutesideal for mimicking natural physiological pulses

Journal of Pineal Research, 72 (2), e12782

Additional Benefits: Burns more fat than standard GLP-1's

It is particularly beneficial for: Individuals struggling with insulin resistance Patients seeking an alternative to insulin therapy Those looking to lose weight while managing blood sugar People with uncontrolled A1C despite using other medications Key Takeaways Tirzepatide works by enhancing insulin secretion, reducing glucagon, slowing digestion, and supporting weight loss

GLP-1 Wonder I like it so far